Hoffmann, R. A wiki for the life sciences where authorship matters. Nature Genetics (2008)

Editor

Personal info

View

About

Terms

Javascript disabled

Please enable Javascript support in your browser to use this application.

Instructions on how to enable JavaScript on different browsers can be found here: http://www.google.com/support/bin/answer.py?answer=23852.

[edit this page]

Chemical Compound Review:

SureCN5933705 ethyl2-[3-(6- chlorobenzothiazol-2...

Synonyms: LS-121243, AC1L2J1U

Welcome! If you are familiar with the subject of this article, you can contribute to this open access knowledge base by deleting incorrect information, restructuring or completely rewriting any text. Read more.

High impact information on Taifun

The inhalation studies were performed in vitro using Andersen Sampler (Ph. Eur.) and Taifun multi-dose dry powder inhalers (DPIs) [1].
In conclusion, 100 micrograms of salbutamol inhaled from Leiras Taifun MDPI offers better protection against Mch-induced bronchoconstriction than 100 micrograms of salbutamol from a pMDI connected to a large volume spacer device [2].

Biological context of Taifun

In this study, a novel multiple dose, reservoir-based Taifun was used as a dry powder inhaler, and the effects of carrier physical properties were evaluated on the pulmonary deposition of budesonide, along with physical stability of the inhalation powder [3].

Analytical, diagnostic and therapeutic context of Taifun

Studies were performed by using novel Taifun multi-dose dry powder inhalers and budesonide as a model compound [4].

References

In vitro evaluation of the effect of cyclodextrin complexation on pulmonary deposition of a peptide, cyclosporin A. Matilainen, L., Järvinen, K., Toropainen, T., Näsi, E., Auriola, S., Järvinen, T., Jarho, P. International journal of pharmaceutics. (2006) [Pubmed]
The bronchoprotective efficacy of salbutamol inhaled from a new metered-dose powder inhaler compared with a conventional pressurized metered-dose inhaler connected to a spacer. Seppälä, O.P., Herrala, J., Hedman, J., Alanko, K., Liipo, K., Terho, E., Pietinalho, A., Nyholm, J.E., Nieminen, M.M. Respiratory medicine. (1998) [Pubmed]
Lactose modifications enhance its drug performance in the novel multiple dose Taifun DPI. Harjunen, P., Lehto, V.P., Martimo, K., Suihko, E., Lankinen, T., Paronen, P., Järvinen, K. European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences. (2002) [Pubmed]
Pulmonary deposition of a budesonide/gamma-cyclodextrin complex in vitro. Kinnarinen, T., Jarho, P., Järvinen, K., Järvinen, T. Journal of controlled release : official journal of the Controlled Release Society. (2003) [Pubmed]

Contributions to this collaborative article are from individual authors of WikiGenes or mined by the WikiGenes Data Mining Engine from MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.About WikiGenes Open Access Licence Privacy Policy Terms of Use apsburg

The world's first wiki where authorship really matters (Nature Genetics, 2008). Due credit and reputation for authors. Imagine a global collaborative knowledge base for original thoughts. Search thousands of articles and collaborate with scientists around the globe.